Quest Diagnostics Inc  (DGX)
Other Ticker:  
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
Price: $148.9550 $-0.11 -0.077%
Day's High: $149.545 Week Perf: 1.54 %
Day's Low: $ 148.31 30 Day Perf: 3.02 %
Volume (M): 20 52 Wk High: $ 174.16
Volume (M$): $ 2,919 52 Wk Avg: $138.88
Open: $148.86 52 Wk Low: $120.40

 Market Capitalization (Millions $) 17,577
 Shares Outstanding (Millions) 118
 Employees 47,000
 Revenues (TTM) (Millions $) 10,294
 Net Income (TTM) (Millions $) 1,312
 Cash Flow (TTM) (Millions $) -287
 Capital Exp. (TTM) (Millions $) 401

Quest Diagnostics Inc
We are the nation's leading provider of diagnostic testing, information and related services, providing insights that enable physicians, hospitals, managed care organizations and other healthcare professionals to make decisions to improve health. We offer patients and physicians the broadest access to diagnostic laboratory services through our national network of laboratories and patient service centers. We provide interpretive consultation through the largest medical and scientific staff in the industry, with over 300 physicians and Ph.D.'s around the country. We are the leading provider of esoteric testing, including gene-based testing, and testing for drugs of abuse. We are also a leading provider of anatomic pathology services and testing for clinical trials.

We empower healthcare organizations and clinicians with state-of-the-art information technology solutions that can improve practice management and patient care.

We currently operate a nationwide network of approximately 1,925 patient service centers, principal laboratories located in more than 30 major metropolitan areas throughout the United States, and approximately 155 smaller "rapid response" laboratories (including, in each case, facilities operated at our joint ventures). We are the only company in our industry to provide full esoteric testing services, including gene-based testing, on both coasts through our Quest Diagnostics Nichols Institute facilities, located in San Juan Capistrano, California and Chantilly, Virginia. We also have laboratory facilities in Mexico City, Mexico and San Juan, Puerto Rico and near London, England.

Clinical laboratory testing is an essential element in the delivery of healthcare services. Physicians use laboratory tests to assist in the detection, diagnosis, evaluation, monitoring and treatment of diseases and other medical conditions. Clinical laboratory testing is generally categorized as clinical testing and anatomic pathology testing. Clinical testing is performed on body fluids, such as blood and urine. Anatomic pathology testing is performed on tissues and other samples, such as human cells. Most clinical laboratory tests are considered routine and can be performed by most commercial clinical laboratories. Tests that are not routine and that require more sophisticated equipment and highly skilled personnel are considered esoteric tests. Esoteric tests, including gene-based tests, are generally referred to laboratories that specialize in performing those tests.


Our laboratory testing business consists of routine testing, esoteric testing, and clinical trials testing.


Routine tests measure various important bodily health parameters such as the functions of the kidney, heart, liver, thyroid and other organs. Commonly ordered tests include:

o blood cholesterol level tests;

o complete blood cell counts;

o Pap tests;

o HIV-related tests;

o urinalyses;

o pregnancy and other prenatal tests; and

o alcohol and other substance-abuse tests.


Esoteric tests are those tests that require more sophisticated technology, equipment and materials, professional "hands-on" attention and more highly skilled professional and technical personnel, and may be performed less frequently than routine tests. Because it is not cost-effective for most clinical laboratories to perform a low volume of esoteric tests in-house, they generally refer many of these tests to an esoteric clinical testing laboratory that specializes in performing these more complex tests. Due to their complexity, esoteric tests are generally reimbursed at higher levels than routine tests.
These esoteric tests are generally in the following fields:

o endocrinology and metabolism (the study of glands, their hormone
secretions and their effects on body growth and metabolism);

o genetics (the study of chromosomes, genes and their protein products and effects);

o hematology (the study of blood and bone marrow cells) and coagulation (the process of blood clotting);

o immunology (the study of the immune system including antibodies, immune system cells and their effects);

o microbiology and infectious diseases (the study of microscopic forms of life including bacteria, viruses, fungi and other infectious agents);

o oncology (the study of abnormal cell growth including benign tumors and cancer);

o serology (a science dealing with the body fluids and their analysis, including antibodies, proteins and other characteristics);

o special chemistry (more sophisticated testing requiring special expertise and technology); and

o toxicology (the study of chemicals and drugs and their effects on the body's metabolism).


While there has been significant consolidation in the clinical laboratory testing business in recent years, our industry remains fragmented and highly competitive. We compete with three types of laboratory providers: hospital-affiliated laboratories, other commercial clinical laboratories and physician-office laboratories. We are the leading clinical laboratory provider in the United States

   Company Address: 500 Plaza Drive Secaucus, 7094 NJ
   Company Phone Number: 520-2700   Stock Exchange / Ticker: NYSE DGX
   DGX is expected to report next financial results on February 27, 2023.

Customers recorded net loss Customers recorded net loss

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


Stock Performances by Major Competitors

5 Days Decrease / Increase
LH        1.72% 
• View Complete Report

Marathon Oil Corporation

EPS Rose by 430.43 % at the Oil And Gas Production company during the financial third quarter of 2022

Marathon Oil Corporation delivered very bewildering earnings in the July to September 30 2022, where Sales soared by 54.646 % to $2.25 billions, while company's income per share soared by 430.43 % to $1.22 per share, from the similar reporting period a year prior.